These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


842 related items for PubMed ID: 29482604

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
    Zhou Z, Xu A, Teng J, Wang F, Tan Y, Liu H, Cheng X, Su Y, Shi H, Hu Q, Chi H, Li J, Hou J, Sun Y, Yang C, Ye J.
    J Immunol Res; 2020; 2020():2180708. PubMed ID: 33224991
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.
    Siegert CE, Daha MR, Tseng CM, Coremans IE, van Es LA, Breedveld FC.
    Ann Rheum Dis; 1993 Dec; 52(12):851-6. PubMed ID: 8311534
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
    Pradhan V, Pandit P, Rajadhyaksha A, Patwardhan M, Surve P, Kamble P, Lecerf M, Bayry J, Kaveri S, Ghosh K, Nadkar MY.
    J Assoc Physicians India; 2016 May; 64(5):14-18. PubMed ID: 27735143
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E, Tănăsescu C, Bălănescu P, Olteanu R, Badea C, Petruţescu B, Grancea C, Vagu C, Bleotu C, Ruţă S, Ardeleanu C.
    Rom J Intern Med; 2010 May; 48(2):159-63. PubMed ID: 21428180
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
    Sjöwall C, Zapf J, von Löhneysen S, Magorivska I, Biermann M, Janko C, Winkler S, Bilyy R, Schett G, Herrmann M, Muñoz LE.
    Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. 9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus.
    Jenks SA, Palmer EM, Marin EY, Hartson L, Chida AS, Richardson C, Sanz I.
    Arthritis Rheum; 2013 Dec; 65(12):3165-75. PubMed ID: 23983101
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 43.